Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

This early-stage trial tests a new drug called FXB0871 in adults with advanced solid tumors, including lung and liver cancers, that have not responded to standard treatments. The study aims to find the safest dose and check if the drug can shrink tumors. About 138 participants wi…

This study tests two drugs, luvometinib and anlotinib, together in people with advanced KRAS-mutated non-small cell lung cancer that has worsened after prior treatment. The goal is to see if the combination can shrink tumors. About 48 adults aged 18-75 will take part. This is not…

This study tests an experimental drug called FXS6837 in about 60 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants will receive either the drug or a placebo for 6 months to see if it lowers protein levels in urine, a sign of kidney damage…

This early-phase study tests a new drug called FXS887 in 14 people with advanced solid tumors that no longer respond to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can help control the cancer. Participants will receive FXS…